Clinical trial results showed that the vaccine developed by NIH and Moderna is 94.1% effective in preventing symptomatic COVID-19.

Researchers deciphered how the human brain navigates physical spaces and keeps track of other people in real-world scenarios.

Researchers designed a system to effectively deliver drugs across the blood brain barrier in mice using nanoparticles.